# Kéranova

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/keranova

- Industry: Medical Devices & Equipment
- Headquarters: Saint-Étienne, France
- Website: www.keranova.fr
- Total disclosed funding: $7.5M
- Latest round: Series B (Aug 16, 2019)
- Investors on record: 6

## About

Kéranova is a French company specializing in innovative ophthalmic surgical devices, enhancing cataract and refractive surgeries through advanced technology that improves accuracy and efficiency.Founded in 2015 and headquartered in Saint-Étienne, France, Kéranova focuses on developing state-of-the-art ophthalmic surgical solutions. The company has completed a total of 4 deals, with its latest funding round being a Series B, raising EUR 6.33 mn on October 10, 2023. Throughout its history, Kéranova has maintained a consistent strategy towards innovation in surgical technology.Kéranova specializes in innovative ophthalmic surgical devices, with its flagship product being the FemtoMatrix®. This device integrates advanced photonic technology to facilitate a unique surgical process known as Photoemulsification®, enhancing surgical accuracy and speed. The FemtoMatrix® automates anterior segment surgeries, reducing reliance on semi-manual techniques. Kéranova's products target hospitals and specialized ophthalmic clinics across Europe and North America, focusing on improving surgical outcomes for cataract and refractive surgery patients.In 2023, Kéranova generated revenue of EUR 4,162,759.30 with an EBITDA of EUR -4,759,891.60. The company's revenue model is based on the direct sale of its FemtoMatrix® device to healthcare institutions, typically through B2B partnerships. These transactions may include support services to ensure clients maximize the use of Kéranova's technology.In October 2023, Kéranova raised EUR 6.33 mn in Series B funding, aimed at supporting the development of new surgical products and expanding into new markets. The company plans to launch additional products within the next year, targeting expansion into North America and Asia by 2025. The recent funding will facilitate research and development efforts, ensuring Kéranova continues to innovate and enhance its offerings.

## Funding rounds

- Series B, Aug 16, 2019, $4.4M — CEA Investissement, Amundi, Merieux Equity Partners, Tourrette Investissements, Supernova Invest, Montpensier Arbevel
- Series A, Mar 11, 2016, $3.2M — CEA Investissement, Merieux Equity Partners

## Investors

- CEA Investissement (https://capitalatlas.ai/funds/cea-investissement) — Series A, Series B
- Merieux Equity Partners (https://capitalatlas.ai/funds/merieux-equity-partners) — Series A, Series B
- Amundi (https://capitalatlas.ai/funds/amundi) — Series B
- Tourrette Investissements — Series B
- Supernova Invest (https://capitalatlas.ai/funds/supernova-invest) — Series B
- Montpensier Arbevel (https://capitalatlas.ai/funds/montpensier-arbevel) — Series B